Literature DB >> 8266982

Contemporary therapy of prolactin-secreting adenomas.

D Tonner1, J Schlechte.   

Abstract

Prolactin-secreting pituitary tumors are common benign pituitary neoplasm that cause amenorrhea, galactorrhea, and infertility. Inhibition of prolactin secretion by a dopamine agonist restores menses and reduces tumor size. This article outlines an approach to therapy and discusses the use of estrogen in women with prolactinomas.

Entities:  

Mesh:

Year:  1993        PMID: 8266982     DOI: 10.1097/00000441-199312000-00008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes.

Authors:  D K Sarkar; K Chaturvedi; S Oomizu; N I Boyadjieva; C P Chen
Journal:  Endocrinology       Date:  2005-06-16       Impact factor: 4.736

Review 2.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

Review 3.  Potential of gene therapy for the treatment of pituitary tumors.

Authors:  R G Goya; D K Sarkar; O A Brown; C B Hereñú
Journal:  Curr Gene Ther       Date:  2004-03       Impact factor: 4.391

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.